| http://www.w3.org/ns/prov#value | - Sandoz (pronounced ???SAN-doh???), the generics arm of Swiss drug maker Novartis, announced the start of a phase-2 trial of rituximab, a biosimilar of Genentech???s Rituxan, used to treat such conditions as non-Hodgkin???s lymphoma and rheumatoid arthritis.
|
